Impact of smoking exposure on disease progression in high risk and very high-risk nonmuscle invasive bladder cancer patients undergoing BCG therapy.
Contieri R, Claps F, Hurle R, Buffi NM, Lughezzani G, Lazzeri M, Aveta A, Pandolfo S, Porpiglia F, Fiori C, Barone B, Crocetto F, Ditonno P, Lucarelli G, Lasorsa F, Busetto GM, Falagario U, Giudice FD, Maggi M, Cantiello F, Borghesi M, Terrone C, Bove P, Antonelli A, Veccia A, Mari A, Luzzago S, Todea-Moga C, Minervini A, Musi G, Fallara G, Mistretta FA, Bianchi R, Tozzi M, Soria F, Gontero P, Marchioni M, Janello LMI, Terracciano D, Russo GI, Schips L, Perdonà S, Tataru OS, Vartolomei MD, Autorino R, Catellani M, Sighinolfi C, Montanari E, Stasi SMD, Rocco B, de Cobelli O, Ferro M.
Contieri R, et al. Among authors: marchioni m.
Urol Oncol. 2024 Dec 12:S1078-1439(24)00748-8. doi: 10.1016/j.urolonc.2024.11.015. Online ahead of print.
Urol Oncol. 2024.
PMID: 39672689